Home-Based Primary Care Led-Outbreak Mitigation in Assisted Living Facilities in the First 100 Days of Coronavirus Disease 2019.


Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 14 05 2020
revised: 08 06 2020
accepted: 08 06 2020
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 31 7 2020
Statut: ppublish

Résumé

Residents of congregate care settings have been severely impacted by the current Coronavirus disease 2019 (COVID-19) pandemic. In this report, we describe the methods our home-based primary care practice has developed to mitigate the spread of COVID-19 in assisted living facilities (ALFs) and we present an initial evaluation of this innovation. Shortly after the first COVID-19 case was reported in the United States, our organization assembled an outbreak committee, designed to support the 1794 ALF residents and the 101 communities in which they reside. The committee led the development and deployment of a comprehensive COVID-19 prevention and suppression strategy. The average age of the cohort was 83 ± 11 years, and 74% were female. Seven individuals (0.4% of census) tested positive for SARS-CoV-2. The positive individuals were located in 3 ALFs, representing 3% of our total number of ALFs. There has been 1 death. Home-based primary care-led outbreak mitigation may be an enabler to suppress COVID-19 in ALFs.

Identifiants

pubmed: 32674826
pii: S1525-8610(20)30519-3
doi: 10.1016/j.jamda.2020.06.014
pmc: PMC7287415
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

951-953

Informations de copyright

Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Am Med Dir Assoc. 2020 May;21(5):572-575
pubmed: 32334770

Auteurs

William R Mills (WR)

BrightSpring Health Services, Louisville, KY. Electronic address: William.Mills@brightspringhealth.com.

Janet M Buccola (JM)

BrightSpring Health Services, Louisville, KY.

Susan Sender (S)

BrightSpring Health Services, Louisville, KY.

Joseph Lichtefeld (J)

BrightSpring Health Services, Louisville, KY.

Nicholas Romano (N)

BrightSpring Health Services, Louisville, KY.

Karen Reynolds (K)

BrightSpring Health Services, Louisville, KY.

Melissa Price (M)

BrightSpring Health Services, Louisville, KY.

Jennifer Phipps (J)

BrightSpring Health Services, Louisville, KY.

Leigh White (L)

BrightSpring Health Services, Louisville, KY.

Shauen Howard (S)

BrightSpring Health Services, Louisville, KY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH